However, the corporate activity that would follow post FDA approval, will be ravenous, it will be efficient and it will be take hold at a speed the retail investor is not accustomed to.
It's rather convenient that a bit of consternation has been tossed into the mix regarding glysophate in the moments before an FDA approval is delivered, or not delivered. Certainly makes shorting the stock quite attractive in the short term, the effect lowering the price for a long term hold.
Nufarm are on the cusp of a monumental development, why not take it down a few pegs to get some cheap seats for the main party...
NUF Price at posting:
$3.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)